Osteopenia Clinical Trials
Here are the 6 most popular medical studies for osteopenia
Behavioural Intervention
Standard of care acceptance-based behavioral weight loss program +1 More for Non-Alcoholic Fatty Liver Disease
This trial will compare a weight loss program and occupational therapy to see if they improve weight, quality of life, and liver health in adults with metabolic associated-dysfunction steatotic liver disease and steatohepatitis.
Whey Protein Isolate for Perimenopause
This trial aims to understand how exercise and nutrition affect metabolism and muscle mass during and after menopause. It will test how HIIT and aerobic exercise combined with pre-exercise protein or carbs, impacts metabolic responses in overweight/obese women.
Popular filter options for osteopenia trials
Metabolic Syndrome Clinical Trials
View 37 Metabolic Syndrome medical studies.
Behavioural Intervention
Glucose +1 More for Insulin Resistance
This trialinvestigates how insulin resistance affects brain aging & whether alternate metabolic pathways (ketones vs. glucose) can counteract it. Subjects will be tested in a within-subjects design with neuroimaging & cognitive tasks, monitored with blood tests.
Behavioral Intervention
Precision Nutrition and Metabolic Function in Obesity and Insulin Resistance
This trial is testing different diets to see which is best for people with obesity who are at risk for heart and metabolic problems. It will also study why some people with obesity don't have these problems while others do.
Polyphenol Supplement
Powdered Tart Cherry for Metabolic Syndrome
This trial aims to test the effects of tart cherry supplements on MetSyn, a growing health concern linked to cardiovascular diseases & type II diabetes, with treatment including exercise & weight loss.
Obesity Clinical Trials
View 18 Obesity medical studies.
Behavioral Intervention
Precision Nutrition and Metabolic Function in Obesity and Insulin Resistance
This trial is testing different diets to see which is best for people with obesity who are at risk for heart and metabolic problems. It will also study why some people with obesity don't have these problems while others do.
Behavioural Intervention
Intermittent Fasting for Type 2 Diabetes
This trial will examine if IF can improve the ability of the pancreas to produce insulin in people with early T2DM, as it has been shown to improve cardio-metabolic function and reduce sugar levels.
Behavioural Intervention
Dietary Manipulation for Insulin Resistance, Inflammation, and Obesity
This trial is testing whether different weight-loss diets can help people with obesity avoid developing obesity-related conditions like type 2 diabetes and heart disease.
Behavioral Intervention
HARMONY + NEEW for Cardiometabolic Risk in African American Women
This trial will test if a special diet and exercise plan will help African-American women stay on track with healthier eating and exercise habits by improving how well they manage themselves, handle stress, and see themselves positively.
Behavioral Intervention
HABIT and TRE to Improve Cardiometabolic Health
This trial will compare the effects of two different types of diets on weight loss, metabolism, and circadian biology in adults who are overweight or obese. The first diet is a time-restricted diet, where people eat whatever they want but only during a 10-hour window each day. The second diet is a more traditional diet where people eat whatever they want but try to limit their overall daily calorie intake. The investigators hypothesize that the time-restricted diet will be more effective than the traditional diet in terms of weight loss and improvement of metabolism.
Osteopenia Clinical Trials With No Placebo
View 98 osteopenia medical studies that do not have a placebo group.
Procedure
Core Decompression +1 More for Osteonecrosis of the Femoral Head
This trial seeks to find the best treatment for a musculoskeletal disease (ONFH) that causes pain, loss of function and may require hip replacement. It compares different joint-preserving treatments to see which works best.
Behavioural Intervention
Glucose +1 More for Insulin Resistance
This trialinvestigates how insulin resistance affects brain aging & whether alternate metabolic pathways (ketones vs. glucose) can counteract it. Subjects will be tested in a within-subjects design with neuroimaging & cognitive tasks, monitored with blood tests.
View More Osteopenia Trials
See another 70 many medical studies focused on osteopenia.
Frequently Asked Questions
Introduction to osteopenia
What are the top hospitals conducting osteopenia research?
When it comes to clinical trials focused on osteopenia, a condition characterized by low bone mass and an increased risk of fractures, several hospitals are leading the way. In Saint Louis, Washington University School of Medicine is currently conducting four active trials for osteopenia. Although they don't have any past trials specifically dedicated to this condition, their commitment to ongoing research highlights their dedication in understanding and treating osteopenia. Meanwhile, the University of Alabama at Birmingham has three active trials and two previously conducted studies on record since 2012, demonstrating their investment in finding innovative approaches for managing this condition.
Notably, the prestigious Mayo Clinic located in Rochester recently initiated its first osteopenia trial in 2020 but already has two ongoing trials highlighting their eagerness to contribute new insights into this field. Similarly committed to advancing our understanding of osteopenia is the University of Missourif Alabama at Birmingham has three active trials and two previously conducted studies on record since 2012, demonstrating their investment in finding innovative approaches for managing this condition.
Notably, the prestigious Mayo Clinic located in Rochester recently initiated its first osteopenia trial in 2020 but already has two ongoing trials highlighting their eagerness to contribute new insights into this field. Similarly committed to advancing our understanding of osteopenia is the University of Missouri-Columbia with two active clinical trials; however, they haven't conducted any previous investigations on this particular topic.
It's also worth mentioning that the National Institutes of Health Clinical Center situated in Bethesda holds an impressive track record with four completed studies focused on osteopenia since recording its first trial back in 2004. Currently engaged in two active clinical trials for this condition as well, their expertise positions them as a valuable resource for individuals seeking cutting-edge advancements regarding osteopenia management.
These hospitals collectively represent medical centers at various stages along the journey towards unlocking new knowledge about osteopenia prevention and treatment options. Their endeavors underscore how each research study contributes significantly to our ever-growing understanding of this complex disease—a stepping stone toward improving lives affected by weak bones and fractures.
Which are the best cities for osteopenia clinical trials?
For individuals seeking clinical trials related to osteopenia, several cities have emerged as notable hubs for research and development. Toronto in Ontario stands out with 10 ongoing trials exploring treatments like Metformin, Healthy Volunteers, and Chemoradiotherapy with Integrated Boost Dose. Atlanta in Georgia follows closely behind with 6 active studies focusing on interventions such as Dulaglutide Injection and Magnetic Resonance Spectroscopic Imaging. Additionally, Birmingham in Alabama and New York City both offer promising opportunities for participation in osteopenia clinical trials, each hosting 5 ongoing studies that investigate various treatments ranging from PET imaging to virtual reality exergaming. Lastly, New Brunswick in New Jersey completes this list of top cities for osteopenia clinical trials with its own set of diverse studies examining factors like metabolic activity of HR+/Her2- breast cancern New Jersand New York City both offer promising opportunities for participation in osteopenia clinical trials, each hosting 5 ongoing studies that investigate various treatments ranging from PET imaging to virtual reality exergaming. Lastly, New Brunswick in New Jersey completes this list of top cities for osteopenia clinical trials with its own set of diverse studies examining factors like metabolic activity of HR+/Her2- breast cancer and tailored lighting intervention. These cities provide valuable access to cutting-edge research efforts aimed at uncovering innovative approaches towards managing osteopenia and improving patient outcomes.
Which are the top treatments for osteopenia being explored in clinical trials?
In the realm of osteopenia, clinical trials are exploring various treatments to combat this condition. One treatment at the forefront is exercise, which shows promising results in two active trials dedicated to osteopenia. Since its first listing in 2001, exercise has been subject to two all-time clinical trials focused on this bone health issue. These studies shed light on the potential benefits that physical activity can bring for individuals with osteopenia, offering a non-pharmacological approach worth considering.
What are the most recent clinical trials for osteopenia?
Exciting developments in osteopenia research have brought forth several recent clinical trials that hold promise for improved treatment options. One such trial explores the potential benefits of a fasting mimicking diet, aiming to determine its efficacy in managing osteopenia. Another study focuses on an intensive lifestyle intervention combined with tirzepatide, seeking to assess their combined impact on this condition. Additionally, vericiguat is being investigated for its potential role in treating osteopenia, while virtual reality exergaming and decitabine are also being explored as novel interventions. These ongoing trials offer hope for advancing our understanding and management of osteopenia moving forward.
What osteopenia clinical trials were recently completed?
Recently completed clinical trials have shed light on innovative approaches in the realm of osteopenia treatment. In December 2019, Roswell Park Cancer Institute concluded a trial investigating the efficacy of Denosumab in addressing this condition. Another notable study, sponsored by Masonic Cancer Center at the University of Minnesota, explored the use of Calcium and vitamin Df Minnesoark Cancer Institute concluded a trial investigating the efficacy of Denosumab in addressing this condition. Another notable study, sponsored by Masonic Cancer Center at the University of Minnesota, explored the use of Calcium and vitamin D and was completed in February 2015. These trials hold promise for advancing our understanding and management of osteopenia, providing potential avenues for improved care for individuals affected by this bone disorder.